Understanding cytotoxicity and cytostaticity in a high-throughput screening collection

ACS Chemical Biology

Volumn 11, Issue 11, 2016, Pages 3007-3023

  Mervin, Lewis H ^a   Cao, Qing ^b   Barrett, Ian P ^b   Firth, Mike A ^b   Murray, David ^b   McWilliams, Lisa ^b   Haddrick, Malcolm ^b   Wigglesworth, Mark ^b   Engkvist, Ola ^c   Bender, Andreas ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; CYTOTOXIC AGENT;

ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; CYTOSTASIS; CYTOSTATICITY; CYTOTOXICITY; DNA DAMAGE RESPONSE; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; METABOLISM; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; CELL CYCLE; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; PROCEDURES;

CELL CYCLE; CELL LINE; CELL SURVIVAL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS;

EID: 84996843153     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.6b00538     Document Type: Article

References (67)

1. Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., Schopfer, U., and Sittampalam, G. S. (2011) Impact of high-throughput screening in biomedical research Nat. Rev. Drug Discovery 10, 188-195 10.1038/nrd3368
2. Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., and Rosenthal, J. (2014) Clinical development success rates for investigational drugs Nat. Biotechnol. 32, 40-51 10.1038/nbt.2786
3. Wigglesworth, M. J., Murray, D. C., Blackett, C. J., Kossenjans, M., and Nissink, J. W. (2015) Increasing the delivery of next generation therapeutics from high throughput screening libraries Curr. Opin. Chem. Biol. 26, 104-110 10.1016/j.cbpa.2015.04.006
4. Rees, S., Gribbon, P., Birmingham, K., Janzen, W. P., and Pairaudeau, G. (2016) Towards a hit for every target Nat. Rev. Drug Discovery 15, 1-2 10.1038/nrd.2015.19
5. Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., Wallace, O., and Weir, A. (2015) An analysis of the attrition of drug candidates from four major pharmaceutical companies Nat. Rev. Drug Discovery 14, 475-486 10.1038/nrd4609
6. Mignani, S., Huber, S., Tomás, H., Rodrigues, J., and Majoral, J. P. (2016) Compound high-quality criteria: a new vision to guide the development of drugs, current situation Drug Discovery Today 21, 573 10.1016/j.drudis.2016.01.005
7. Hoelder, S., Clarke, P. A., and Workman, P. (2012) Discovery of small molecule cancer drugs: successes, challenges and opportunities Mol. Oncol. 6, 155-176 10.1016/j.molonc.2012.02.004
8. Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., and Pangalos, M. N. (2014) Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework Nat. Rev. Drug Discovery 13, 419-431 10.1038/nrd4309
9. Roberts, R. A., Kavanagh, S. L., Mellor, H. R., Pollard, C. E., Robinson, S., and Platz, S. J. (2014) Reducing attrition in drug development: smart loading preclinical safety assessment Drug Discovery Today 19, 341-347 10.1016/j.drudis.2013.11.014
10. Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., Baehrecke, E. H., Bazan, N. G., Bertrand, M. J., Bianchi, K., Blagosklonny, M. V., Blomgren, K., Borner, C., Bredesen, D. E., Brenner, C., Campanella, M., Candi, E., Cecconi, F., Chan, F. K., Chandel, N. S., Cheng, E. H., Chipuk, J. E., Cidlowski, J. A., Ciechanover, A., Dawson, T. M., Dawson, V. L., De Laurenzi, V., De Maria, R., Debatin, K. M., Di Daniele, N., Dixit, V. M., Dynlacht, B. D., El-Deiry, W. S., Fimia, G. M., Flavell, R. A., Fulda, S., Garrido, C., Gougeon, M. L., Green, D. R., Gronemeyer, H., Hajnoczky, G., Hardwick, J. M., Hengartner, M. O., Ichijo, H., Joseph, B., Jost, P. J., Kaufmann, T., Kepp, O., Klionsky, D. J., Knight, R. A., Kumar, S., Lemasters, J. J., Levine, B., Linkermann, A., Lipton, S. A., Lockshin, R. A., López-Otín, C., Lugli, E., Madeo, F., Malorni, W., Marine, J. C., Martin, S. J., Martinou, J. C., Medema, J. P., Meier, P., Melino, S., Mizushima, N., Moll, U., Muñoz-Pinedo, C., Nuñez, G., Oberst, A., Panaretakis, T., Penninger, J. M., Peter, M. E., Piacentini, M., Pinton, P., Prehn, J. H., Puthalakath, H., Rabinovich, G. A., Ravichandran, K. S., Rizzuto, R., Rodrigues, C. M., Rubinsztein, D. C., Rudel, T., Shi, Y., Simon, H. U., Stockwell, B. R., Szabadkai, G., Tait, S. W., Tang, H. L., Tavernarakis, N., Tsujimoto, Y., Vanden Berghe, T., Vandenabeele, P., Villunger, A., Wagner, E. F., Walczak, H., White, E., Wood, W. G., Yuan, J., Zakeri, Z., Zhivotovsky, B., Melino, G., and Kroemer, G. (2015) Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 Cell Death Differ. 22, 58-73 10.1038/cdd.2014.137
11. Chaabane, W., User, S. D., El-Gazzah, M., Jaksik, R., Sajjadi, E., Rzeszowska-Wolny, J., and Los, M. J. (2013) Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer Arch. Immunol. Ther. Exp. 61, 43-58 10.1007/s00005-012-0205-y
12. Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., Gottlieb, E., Green, D. R., Hengartner, M. O., Kepp, O., Knight, R. A., Kumar, S., Lipton, S. A., Lu, X., Madeo, F., Malorni, W., Mehlen, P., Nuñez, G., Peter, M. E., Piacentini, M., Rubinsztein, D. C., Shi, Y., Simon, H. U., Vandenabeele, P., White, E., Yuan, J., Zhivotovsky, B., Melino, G., and Kroemer, G. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Cell Death Differ. 19, 107-120 10.1038/cdd.2011.96
13. Nikoletopoulou, V., Markaki, M., Palikaras, K., and Tavernarakis, N. (2013) Crosstalk between apoptosis, necrosis and autophagy Biochim. Biophys. Acta, Mol. Cell Res. 1833, 3448-3459 10.1016/j.bbamcr.2013.06.001
14. Mariño, G., Niso-Santano, M., Baehrecke, E. H., and Kroemer, G. (2014) Self-consumption: the interplay of autophagy and apoptosis Nat. Rev. Mol. Cell Biol. 15, 81-94 10.1038/nrm3735
15. Hotchkiss, R. S., Strasser, A., McDunn, J. E., and Swanson, P. E. (2009) Cell death N. Engl. J. Med. 361, 1570-1583 10.1056/NEJMra0901217
16. Rixe, O. and Fojo, T. (2007) Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Clin. Cancer Res. 13, 7280-7287 10.1158/1078-0432.CCR-07-2141
17. Lupi, M., Cappella, P., Matera, G., Natoli, C., and Ubezio, P. (2006) Interpreting cell cycle effects of drugs: the case of melphalan Cancer Chemother. Pharmacol. 57, 443-457 10.1007/s00280-005-0044-1
18. Raies, A. B. and Bajic, V. B. (2016) In silico toxicology: computational methods for the prediction of chemical toxicity WIREs Comput. Mol. Sci. 6, 147 10.1002/wcms.1240
19. Cruz-Monteagudo, M., Medina-Franco, J. L., Pérez-Castillo, Y., Nicolotti, O., Cordeiro, M. N., and Borges, F. (2014) Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? Drug Discovery Today 19, 1069-1080 10.1016/j.drudis.2014.02.003
20. Patlewicz, G. and Fitzpatrick, J. M. (2016) Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity Chem. Res. Toxicol. 29, 438-451 10.1021/acs.chemrestox.5b00388
21. Stumpfe, D. and Bajorath, J. (2012) Exploring activity cliffs in medicinal chemistry J. Med. Chem. 55, 2932-2942 10.1021/jm201706b
22. Lin, Z. and Will, Y. (2012) Evaluation of drugs with specific organ toxicities in organ-specific cell lines Toxicol. Sci. 126, 114-127 10.1093/toxsci/kfr339
23. Cortés-Ciriano, I. and Bender, A. (2016) How Consistent are Publicly Reported Cytotoxicity Data? Large-Scale Statistical Analysis of the Concordance of Public Independent Cytotoxicity Measurements ChemMedChem 11, 57-71 10.1002/cmdc.201500424
24. Pohjala, L., Tammela, P., Samanta, S. K., Yli-Kauhaluoma, J., and Vuorela, P. (2007) Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays Anal. Biochem. 362, 221-228 10.1016/j.ab.2006.12.038
25. Liggi, S., Drakakis, G., Koutsoukas, A., Cortes-Ciriano, I., Martínez-Alonso, P., Malliavin, T. E., Velazquez-Campoy, A., Brewerton, S. C., Bodkin, M. J., Evans, D. A., Glen, R. C., Carrodeguas, J. A., and Bender, A. (2014) Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts Future Med. Chem. 6, 2029-2056 10.4155/fmc.14.137
26. Liggi, S., Drakakis, G., Hendry, A. E., Hanson, K. M., Brewerton, S. C., Wheeler, G. N., Bodkin, M. J., Evans, D. A., and Bender, A. (2013) Extensions to in silico bioactivity predictions using pathway annotations and differential pharmacology analysis: application to xenopus laevis phenotypic readouts Mol. Inf. 32, 1009-1024 10.1002/minf.201300102
27. Kelder, T., van Iersel, M. P., Hanspers, K., Kutmon, M., Conklin, B. R., Evelo, C. T., and Pico, A. R. (2012) WikiPathways: building research communities on biological pathways Nucleic Acids Res. 40, D1301-1307 10.1093/nar/gkr1074
28. Flachner, B., Lörincz, Z., Carotti, A., Nicolotti, O., Kuchipudi, P., Remez, N., Sanz, F., Tóvári, J., Szabó, M. J., Bertók, B., Cseh, S., Mestres, J., and Dormán, G. (2012) A chemocentric approach to the identification of cancer targets PLoS One 7, e35582 10.1371/journal.pone.0035582
29. Dempster, E. L., Wong, C. C., Lester, K. J., Burrage, J., Gregory, A. M., Mill, J., and Eley, T. C. (2014) Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression Biol. Psychiatry 76, 977-983 10.1016/j.biopsych.2014.04.013
30. Heo, J., Li, J., Summerlin, M., Hays, A., Katyal, S., McKinnon, P. J., Nitiss, K. C., Nitiss, J. L., and Hanakahi, L. A. (2015) TDP1 promotes assembly of non-homologous end joining protein complexes on DNA DNA Repair 30, 28-37 10.1016/j.dnarep.2015.03.003
31. Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C., and Cantley, L. C. (2004) The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor Nat. Struct. Mol. Biol. 11, 60-66 10.1038/nsmb708
32. Wahdan-Alaswad, R. S., Bane, K. L., Song, K., Shola, D. T., Garcia, J. A., and Danielpour, D. (2012) Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin Mol. Cancer Res. 10, 821-833 10.1158/1541-7786.MCR-11-0615
33. Chawla, S., Kvalnes, K., deLong, M. A., Wickett, R., Manga, P., and Boissy, R. E. (2012) DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis J. Drugs Dermatol 11, e28-34
34. Alahari, S. K., Reddig, P. J., and Juliano, R. L. (2004) The integrin-binding protein Nischarin regulates cell migration by inhibiting PAK EMBO J. 23, 2777-2788 10.1038/sj.emboj.7600291
35. Sun, S., Han, J., Ralph, W. M., Chandrasekaran, A., Liu, K., Auborn, K. J., and Carter, T. H. (2004) Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro Cell Stress Chaperones 9, 76-87 10.1379/1466-1268(2004)009<0076:ERSAAC>2.0.CO;2
36. Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., and Chen, H. (2013) Chemical predictive modelling to improve compound quality Nat. Rev. Drug Discovery 12, 948-962 10.1038/nrd4128
37. Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Prettenhofer, P., Weiss, R., and Dubourg, V. (2011) Scikit-learn: Machine learning in Python Journal of Machine Learning Research 12, 2825-2830
38. Muresan, S., Petrov, P., Southan, C., Kjellberg, M. J., Kogej, T., Tyrchan, C., Varkonyi, P., and Xie, P. H. (2011) Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data Drug Discovery Today 16, 1019-1030 10.1016/j.drudis.2011.10.005
39. Mervin, L. H., Afzal, A. M., Drakakis, G., Lewis, R., Engkvist, O., and Bender, A. (2015) Target prediction utilising negative bioactivity data covering large chemical space J. Cheminf. 7, 51 10.1186/s13321-015-0098-y
40. Koutsoukas, A., Lowe, R., Kalantarmotamedi, Y., Mussa, H. Y., Klaffke, W., Mitchell, J. B., Glen, R. C., and Bender, A. (2013) In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window J. Chem. Inf. Model. 53, 1957-1966 10.1021/ci300435j
41. Coordinators, N. R. (2013) Database resources of the National Center for Biotechnology Information Nucleic Acids Res. 41, D8-D20 10.1093/nar/gks1189
42. Gfeller, D. and Zoete, V. (2015) Protein homology reveals new targets for bioactive small molecules Bioinformatics 31, 2721-2727 10.1093/bioinformatics/btv214
43. OEChem T, version 2.0, OpenEye Scientific Software, Santa Fe, NM.
44. Landrum, G. (2012) RDKit: Open-source cheminformatics. http://www.rdkit.org/.
45. Morgan, H. L. (1965) The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service J. Chem. Doc. 5, 107-113 10.1021/c160017a018
46. Wale, N. and Karypis, G. (2009) Target fishing for chemical compounds using target-ligand activity data and ranking based methods J. Chem. Inf. Model. 49, 2190-2201 10.1021/ci9000376
47. Pico, A. R., Kelder, T., van Iersel, M. P., Hanspers, K., Conklin, B. R., and Evelo, C. (2008) WikiPathways: pathway editing for the people PLoS Biol. 6, e184 10.1371/journal.pbio.0060184
48. Bornot, A., Blackett, C., Engkvist, O., Murray, C., and Bendtsen, C. (2014) The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens J. Biomol. Screening 19, 696-706 10.1177/1087057113518966
49. Thaker, N. G., Zhang, F., McDonald, P. R., Shun, T. Y., Lewen, M. D., Pollack, I. F., and Lazo, J. S. (2009) Identification of survival genes in human glioblastoma cells by small interfering RNA screening Mol. Pharmacol. 76, 1246-1255 10.1124/mol.109.058024
50. Rines, A. K., Burke, M. A., Fernandez, R. P., Volpert, O. V., and Ardehali, H. (2012) Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin FASEB J. 26, 4685-4695 10.1096/fj.12-212282
51. Ansari, D., Andersson, R., Bauden, M. P., Andersson, B., Connolly, J. B., Welinder, C., Sasor, A., and Marko-Varga, G. (2015) Protein deep sequencing applied to biobank samples from patients with pancreatic cancer J. Cancer Res. Clin. Oncol. 141, 369-380 10.1007/s00432-014-1817-x
52. Zha, J., Zhou, Q., Xu, L. G., Chen, D., Li, L., Zhai, Z., and Shu, H. B. (2004) RIP5 is a RIP-homologous inducer of cell death Biochem. Biophys. Res. Commun. 319, 298-303 10.1016/j.bbrc.2004.04.194
53. Wang, L. Y. and Kung, H. J. (2012) Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/CCDH1 Oncogene 31, 2907-2918 10.1038/onc.2011.464
54. Parray, A. A., Baba, R. A., Bhat, H. F., Wani, L., Mokhdomi, T. A., Mushtaq, U., Bhat, S. S., Kirmani, D., Kuchay, S., Wani, M. M., and Khanday, F. A. (2014) MKK6 is upregulated in human esophageal, stomach, and colon cancers Cancer Invest. 32, 416-422 10.3109/07357907.2014.933236
55. Orvedahl, A., Sumpter, R., Jr., Xiao, G., Ng, A., Zou, Z., Tang, Y., Narimatsu, M., Gilpin, C., Sun, Q., Roth, M., Forst, C. V., Wrana, J. L., Zhang, Y. E., Luby-Phelps, K., Xavier, R. J., Xie, Y., and Levine, B. (2011) Image-based genome-wide siRNA screen identifies selective autophagy factors Nature 480, 113-117 10.1038/nature10546
56. MacKeigan, J. P., Murphy, L. O., and Blenis, J. (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance Nat. Cell Biol. 7, 591-600 10.1038/ncb1258
57. Chawla-Sarkar, M., Lindner, D. J., Liu, Y. F., Williams, B. R., Sen, G. C., Silverman, R. H., and Borden, E. C. (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis Apoptosis 8, 237-249 10.1023/A:1023668705040
58. Parker, L. L., Walter, S. A., Young, P. G., and Piwnica-Worms, H. (1993) Phosphorylation and inactivation of the mitotic inhibitor Wee1 by the nim1/cdr1 kinase Nature 363, 736-738 10.1038/363736a0
59. Wroble, B. N., Finkielstein, C. V., and Sible, J. C. (2007) Wee1 kinase alters cyclin E/Cdk2 and promotes apoptosis during the early embryonic development of Xenopus laevis BMC Dev. Biol. 7, 119 10.1186/1471-213X-7-119
60. Qi, J., Su, Y., Sun, R., Zhang, F., Luo, X., Yang, Z., and Luo, X. (2005) CASK inhibits ECV304 cell growth and interacts with Id1 Biochem. Biophys. Res. Commun. 328, 517-521 10.1016/j.bbrc.2005.01.014
61. Pollak, M. N., Schernhammer, E. S., and Hankinson, S. E. (2004) Insulin-like growth factors and neoplasia Nat. Rev. Cancer 4, 505-518 10.1038/nrc1387
62. Valli, E., Trazzi, S., Fuchs, C., Erriquez, D., Bartesaghi, R., Perini, G., and Ciani, E. (2012) CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells Biochim. Biophys. Acta, Gene Regul. Mech. 1819, 1173-1185 10.1016/j.bbagrm.2012.08.001
63. Clemens, M. J. (2001) Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis Prog. Mol. Subcell. Biol. 27, 57-89 10.1007/978-3-662-09889-9-3
64. Zhang, W. and Go, M. L. (2009) Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity Bioorg. Med. Chem. 17, 2077-2090 10.1016/j.bmc.2008.12.052
65. Wang, X., Jiang, W., Duan, N., Qian, Y., Zhou, Q., Ye, P., Jiang, H., Bai, Y., Zhang, W., and Wang, W. (2014) NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression Int. J. Clin. Exp. Pathol. 7, 1677-1686
66. De Felice, B., Garbi, C., Wilson, R. R., Santoriello, M., and Nacca, M. (2011) Effect of selenocystine on gene expression profiles in human keloid fibroblasts Genomics 97, 265-276 10.1016/j.ygeno.2011.02.009
67. Mavrogonatou, E., Papadimitriou, K., Urban, J. P., Papadopoulos, V., and Kletsas, D. (2015) Deficiency in the α1 subunit of Na+/K+-ATPase enhances the anti-proliferative effect of high osmolality in nucleus pulposus intervertebral disc cells J. Cell. Physiol. 230, 3037-3048 10.1002/jcp.25040